Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/18164
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMihaljević, Olgica-
dc.contributor.authorZivancevic-Simonovic, Snezana-
dc.contributor.authorĆupurdija, Vojislav-
dc.contributor.authorMarinkovic, Milos-
dc.contributor.authorTubić Vukajlović, Jovana-
dc.contributor.authorRasic Markovic, Aleksandra-
dc.contributor.authorStanojević Pirković, Marijana-
dc.contributor.authorMilošević-Đorđević, Olivera-
dc.date.accessioned2023-06-07T13:27:26Z-
dc.date.available2023-06-07T13:27:26Z-
dc.date.issued2022-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/18164-
dc.description.abstractBearing in the mind that a variety of agents can contribute to genome instability, including viral infections, the aim of this study was to analyze DNA damage in hospitalized COVID-19 patients and its relationship with certain laboratory parameters. The potential impact of applied therapy and chest X-rays on DNA damage was also estimated. The study population included 24 severely COVID-19 patients and 15 healthy control subjects. The level of DNA damage was measured as genetic damage index (GDI) by comet assay. The standard laboratory methods and certifed enzymatic reagents for the appropriate autoanalyzers were performed for the determination of the biochemical and hematological parameters. COVID-19 patients had signifcantly higher level of DNA damage compared with control subjects. The absolute number of neutrophil leukocytes was statistically higher, while the absolute number of lymphocytes was statistically lower in COVID-19 patients than in healthy controls. The analysis of the relationship between DNA damage and laboratory parameters indicated that GDI was positively correlated with interleukin 6 (IL-6) concentration and negatively with platelet count in COVID-19 patients. The level of DNA damage was slightly higher in female patients, in whom it was demonstrated a positive correlation of GDI with C-reactive protein (CRP) and procalcitonin. Likewise, there was a negative relationship of GDI and platelet count, and positive relationship of GDI and activated partial thromboplastin time (aPTT) in female population. The applied therapy (antibiotics, corticosteroid, anticoagulant, and antiviral therapy) as well as chest X rays has been shown to have genotoxic potential. The level of DNA damage signifcantly corresponds to the infammatory markers and parameters of hemostasis in COVID-19 patients. In conclusion, infammation, smoking habit, applied therapy, and chest X rays contribute to a higher level of DNA damage in COVID-19 patients.en_US
dc.language.isoenen_US
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.sourceMutagenesis-
dc.subjectCOVID-19en_US
dc.subjectDNA damageen_US
dc.subjectinfammationen_US
dc.subjecthemostasis abnormalitiesen_US
dc.titleDNA damage in peripheral blood lymphocytes of severely ill COVID-19 patients in relation to infammatory markers and parameters of hemostasisen_US
dc.typearticleen_US
dc.description.versionPublisheden_US
dc.identifier.doihttps://doi.org/10.1093/mutage/geac011en_US
dc.type.versionPublishedVersionen_US
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

428

Downloads(s)

28

Files in This Item:
File Description SizeFormat 
Covid19, Mutagenesis.pdf716.83 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.